Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial - Fehrenbacher, L; Spira, A; Ballinger, M; POPLAR Study Group (Lancet, 2016)
10.1016/S0140-6736(16)00587-0